New Key Statistics Module, Z-Score and F-Score
NAS:TCRT Key Ratios
| Market Cap $ M | 19.05 |
| Enterprise Value $ M | 14.51 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.05 |
| Price/Sales | 238.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -2.29 |
| Beneish M-Score | 36.31 |
| 10-y EBITDA Growth Rate % | -5.90 |
| 5-y EBITDA Growth Rate % | -48.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.44 |
| EV-to-EBITDA | -0.47 |
| PEG | -- |
| Shares Outstanding M | 16.01 |
| Net Margin (%) | -702,800.00 |
| Operating Margin % | -569,860.00 |
| Pre-tax Margin (%) | -702,800.00 |
| Quick Ratio | 4.22 |
| Current Ratio | 4.22 |
| ROA % (ttm) | -103.84 |
| ROE % (ttm) | -159.84 |
| ROIC % (ttm) | -208.61 |
| Dividend Yield % | -- |
| Altman Z-Score | -161.20 |
TCRT Number of Guru Trades
TCRT Volume of Guru Trades
Gurus Latest Trades with NAS:TCRT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TCRT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Alaunos Therapeutics Inc Insider Transactions
No Available Data
News about NAS:TCRT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers